The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A randomized phase II, open-label study of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC).
Eric Jay Small
No relevant relationships to disclose
Raymond Lance
No relevant relationships to disclose
Thomas A. Gardner
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Research Funding - Dendreon
Lawrence Ivan Karsh
Consultant or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Dendreon; Dendreon; Dendreon; Dendreon; GlaxoSmithKline; GlaxoSmithKline; Janssen Pharmaceutical ; Janssen Pharmaceutical ; Medivation; Medivation; Pfizer; Pfizer
Honoraria - Amgen; Amgen; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Dendreon; Dendreon; Dendreon; Dendreon; GlaxoSmithKline; GlaxoSmithKline; Janssen Pharmaceutical ; Janssen Pharmaceutical ; Medivation; Medivation; Pfizer; Pfizer
Research Funding - Amgen; Argos Therapeutics; Astellas Pharma; Bayer; Dendreon; Dendreon; Dendreon; Dendreon; Endo Pharmaceuticals; GlaxoSmithKline; Janssen Pharmaceutical ; Medivation; NeoGenomics Laboratories; Nymox Pharmaceutical Corporation ; Orion Corporation ; Pfizer; Spectrum Pharmaceuticals
Andrew Stubbs
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Other Remuneration - Dendreon
Candice McCoy
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Todd DeVries
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Charles H. Redfern
Research Funding - Sharp Clinical Oncology Research
Neal D. Shore
Consultant or Advisory Role - Amgen; Amgen; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Dendreon; Dendreon; Janssen Pharmaceutical ; Janssen Pharmaceutical ; Sanofi ; Sanofi